Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
Days after suffering a rejection in Australia, the Alzheimer’s drug hit another roadblock in the U.K., which found the drug ...
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback